Literature DB >> 20444931

Stand UP!

Janet Rubin, Clinton Rubin.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20444931      PMCID： PMC2869553          DOI： 10.1210/jc.2010-0608

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  24 in total

1.  The anabolic activity of bone tissue, suppressed by disuse, is normalized by brief exposure to extremely low-magnitude mechanical stimuli.

Authors:  C Rubin; G Xu; S Judex
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

2.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Authors:  Donald A Glass; Peter Bialek; Jong Deok Ahn; Michael Starbuck; Millan S Patel; Hans Clevers; Mark M Taketo; Fanxin Long; Andrew P McMahon; Richard A Lang; Gerard Karsenty
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

3.  Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease.

Authors:  Gabriela G Loots; Michaela Kneissel; Hansjoerg Keller; Myma Baptist; Jessie Chang; Nicole M Collette; Dmitriy Ovcharenko; Ingrid Plajzer-Frick; Edward M Rubin
Journal:  Genome Res       Date:  2005-06-17       Impact factor: 9.043

4.  Longitudinal study of bone turnover after acute spinal cord injury.

Authors:  D Roberts; W Lee; R C Cuneo; J Wittmann; G Ward; R Flatman; B McWhinney; P E Hickman
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

5.  Marrow changes in paraplegic patients.

Authors:  P Minaire; C Edouard; M Arlot; P J Meunier
Journal:  Calcif Tissue Int       Date:  1984-05       Impact factor: 4.333

6.  Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss.

Authors:  Agostino Gaudio; Pietra Pennisi; Cornelia Bratengeier; Venerando Torrisi; Brigitte Lindner; Roberto A Mangiafico; Ivana Pulvirenti; Gerhard Hawa; Giovanni Tringali; Carmelo E Fiore
Journal:  J Clin Endocrinol Metab       Date:  2010-03-19       Impact factor: 5.958

7.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

8.  Resistance exercise as a countermeasure to disuse-induced bone loss.

Authors:  L C Shackelford; A D LeBlanc; T B Driscoll; H J Evans; N J Rianon; S M Smith; E Spector; D L Feeback; D Lai
Journal:  J Appl Physiol (1985)       Date:  2004-07

Review 9.  Mechanical signals as anabolic agents in bone.

Authors:  Engin Ozcivici; Yen Kim Luu; Ben Adler; Yi-Xian Qin; Janet Rubin; Stefan Judex; Clinton T Rubin
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

10.  Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.

Authors:  Rutger L van Bezooijen; Bernard A J Roelen; Annemieke Visser; Lianne van der Wee-Pals; Edwin de Wilt; Marcel Karperien; Herman Hamersma; Socrates E Papapoulos; Peter ten Dijke; Clemens W G M Löwik
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307
View more
  1 in total

1.  Mechanical signal influence on mesenchymal stem cell fate is enhanced by incorporation of refractory periods into the loading regimen.

Authors:  Buer Sen; Zhihui Xie; Natasha Case; Maya Styner; Clinton T Rubin; Janet Rubin
Journal:  J Biomech       Date:  2010-12-04       Impact factor: 2.712
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.